Europe Drug-Device Combination Market – Industry Trends and Forecast to 2028

Customize Your Report Customize Your Report Buy Now Buy Now Free Sample Report Free Sample Report
back-icon

Back to Report
Home Healthcare Europe Drug Device Combination Market Table of Content
Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Europe Drug-Device Combination Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Published Report
  • Sep 2021
  • Europe
  • 350 Pages
  • No of Tables: 85
  • No of Figures: 46
Buy Now Buy Now Request for Sample Request for Sample
Nucleus Nucleus

Table of Content

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of EUROPE DRUG-DEVICE COMBINATION MARKET
    4. LIMITATIONS
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. PRODUCT type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. market application coverage grid
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insights
    1. PATENT ANALYSIS
      1. MANUFACTURING PROCESS OF COMBINATION PRODUCTS
      2. APPROVAL BY AGENCY
      3. PATENT GRANT
      4. PATENT CERTIFICATIONS:
  5. Pipeline analysis
  6. REGULATORY FRAMEWORKS:
    1. U.S.
    2. EUROPE
    3. CANADA
    4. AUSTRALIA
    5. JAPAN
    6. CHINA
    7. SOUTH KOREA
  7. regional Summary
    1. North America Drug-Device Combination Market
      1. OVERVIEW
    2. Europe Drug-Device Combination Market
      1. OVERVIEW
    3. Asia-Pacific Drug-Device Combination Market
      1. OVERVIEW
    4. Middle East and Africa Drug-Device Combination Market
      1. OVERVIEW
    5. South America Drug-Device Combination Market
      1. OVERVIEW
  8. Market Overview
    1. Drivers
      1. INCREASING PREVALENCE OF chronic diseases
      2. Growing geriatric population
      3. Escalation in innovation and technologies
      4. Rising rates of obesity
    2. RESTRAINTS
      1. product recalls
      2. Risk associated with the combiNAtion products
    3. opportunities
      1. RISING EXPENDITURE ON HEALTHCARE
      2. STRATEGIC INITIATIVES BY KEY MARKET PLAYERS
      3. Growing support by healthcare organizations and government bodies
      4. INCREASE IN R&D ACTIVITIES BY MEDICAL DEVICE COMPANIES
    4. Challenge
      1. STRICT REGULATORY FRAMEWORK
  9. Impact Of COVID-19 Pandemic On The Europe Drug-Device Combination Market
    1. IMPACT ON PRICE
    2. IMPACT ON SUPPLY CHAIN
    3. IMPACT ON DEMAND
    4. STRATEGIC DECISIONS FOR MANUFACTURERS
    5. CONCLUSION
  10. EUROPE DRUG-DEVICE COMBINATION MARKET, By product
    1. overview
    2. Auto-Injector
      1. WEARABLE AUTO-INJECTOR
      2. HAND HELD AUTO-INJECTOR
    3. Microneedle Patch
    4. digital pill
    5. Smart Inhaler
    6. Drug Delivery Hydrogels
    7. Drug-Eluting Lens
    8. others
  11. EUROPE DRUG-DEVICE COMBINATION MARKET, By application
    1. overview
    2. Orthopedic Diseases
    3. Respiratory Diseases
    4. Diabetes
    5. Oncology
    6. Cardiovascular Diseases
    7. others
  12. Europe drug-device combination MARKET, BY end user
    1. overview
    2. clinics
    3. hospitals
    4. home care settings
    5. ambulatory care centers
    6. others
  13. Europe drug-device combination MARKET, BY distribution channel
    1. overview
    2. direct tender
    3. retails sales
    4. others
  14. EUROPE drug-device combination MARKET, BY REGION
    1. Europe
      1. germany
      2. france
      3. u.k.
      4. italy
      5. spain
      6. russia
      7. switzerland
      8. turkey
      9. belgium
      10. netherlands
      11. rest of europe
  15. Europe Drug-device combination Market: COMPANY landscape
    1. company share analysis: Europe
  16. Swot analysis
  17. Company profile
    1. Janssen Pharmaceuticals, Inc. (a subsidiary of Johnson & Johnson Services, Inc.)
      1. COMPANY SNAPSHOT
      2. Revenue analysis
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. Recent development
    2. Amgen Inc.
      1. COMPANY SNAPSHOT
      2. Revenue analysis
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTs
    3. GlaxoSmithKline plc
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    4. BD
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. recent developmentS
    5. MEDTRONIC
      1. COMPANY SNAPSHOT
      2. Revenue analysis
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    6. Bayer AG
      1. COMPANY SNAPSHOT
      2. Revenue analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    7. CGBIO
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    8. CosMED Pharmaceutical Co.Ltd.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    9. E3D Elcam Drug Delivery Devices
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    10. Eitan Medical
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    11. EOFLOW CO., LTD.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    12. Findair Sp. z o. o.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    13. Insulet Corporation
      1. COMPANY SNAPSHOT
      2. Revenue analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    14. Mediprint
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    15. MetP Pharma AG
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    16. Micron Biomedical, Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    17. NanoPass
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    18. OcuMedic
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    19. Otsuka America Pharmaceutical, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    20. PROPELLER HEALTH
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    21. RAPHAS CO., LTD.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    22. Sensirion AG Switzerland
      1. COMPANY SNAPSHOT
      2. revenue analysis
      3. PRODUCT PORTFOLIO
      4. Recent development
    23. . SONCEBOZ
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    24. Subcuject Aps
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    25. TheraJect
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    26. Vaxess Technologies Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    27. VAXXAS
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    28. YPSOMED
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    29. Zimmer Biomet
      1. COMPANY SNAPSHOT
      2. Revenue analysis
      3. PRODUCT PORTFOLIO
      4. Recent development
  18. questionnaire
  19. related reports

List of Table

TABLE 1 Europe DRUG-DEVICE COMIBINATION Market, pipeline analysis

TABLE 2 Most obese countries of Asia-Pacific 2020

TABLE 3 EUROPE DRUG-DEVICE COMBINATION MARKET, By Product, 2019-2028 (USD million)

TABLE 4 Europe Auto-Injector in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 5 Europe Auto-Injector in Drug-Device Combination Market, By Product, 2019-2028 (USD Million)

TABLE 6 Europe Microneedle Patch in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 7 Europe Digital Pill in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 8 Europe Smart Inhaler in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 9 Europe Drug Delivery Hydrogels in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 10 Europe Drug-Eluting Lens in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 11 Europe Others in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 12 Europe Drug-Device Combination Market, By Application, 2019-2028 (USD Million)

TABLE 13 Europe Orthopedic Diseases in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 14 Europe Respiratory Diseases in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 15 Europe Diabetes in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 16 Europe Oncology in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 17 Europe Cardiovascular Diseases in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 18 Europe Others in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 19 Europe drug-device combination Market, By end user, 2019-2028 (USD MILLION)

TABLE 20 Europe clinics in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 21 Europe hospitals in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 22 Europe home care settings in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 23 Europe ambulatory care centers in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 24 Europe ambulatory care centers in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 25 Europe drug-device combination MARKET, By distribution channel 2019-2028 (USD MILLION)

TABLE 26 Europe direct tender in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 27 Europe retail sales in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 28 Europe others in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 29 EUROPE DRUG-DEVICE COMBINATION market, By Country, 2019-2028 (USD Million)

TABLE 30 EUROPE DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 31 EUROPE AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 32 EUROPE DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 33 EUROPE DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 34 EUROPE DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 35 GERMANY DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 36 GERMANY AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 37 GERMANY DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 38 GERMANY DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 39 GERMANY DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 40 FRANCE DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 41 FRANCE AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 42 FRANCE DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 43 FRANCE DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 44 FRANCE DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 45 U.K. DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 46 U.K. AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 47 U.K. DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 48 U.K. DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 49 U.K. DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 50 ITALY DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 51 ITALY AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 52 ITALY DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 53 ITALY DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 54 ITALY DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 55 SPAIN DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 56 SPAIN AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 57 SPAIN DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 58 SPAIN DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 59 SPAIN DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 60 RUSSIA DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 61 RUSSIA AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 62 RUSSIA DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 63 RUSSIA DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 64 RUSSIA DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 65 SWITZERLAND DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 66 SWITZERLAND AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 67 SWITZERLAND DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 68 SWITZERLAND DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 69 SWITZERLAND DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 70 TURKEY DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 71 TURKEY AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 72 TURKEY DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 73 TURKEY DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 74 TURKEY DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 75 belgium DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 76 BELGIUM AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 77 BELGIUM DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 78 BELGIUM DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 79 BELGIUM DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 80 NETHERLANDS DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 81 NETHERLANDS AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 82 NETHERLANDS DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 83 NETHERLANDS DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 84 NETHERLANDS DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 85 REST OF EUROPE DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

List of Figure

FIGURE 1 EUROPE DRUG-DEVICE COMBINATION MARKET: segmentation

FIGURE 2 EUROPE DRUG-DEVICE COMBINATION MARKET: data triangulation

FIGURE 3 EUROPE DRUG-DEVICE COMBINATION MARKET: DROC ANALYSIS

FIGURE 4 EUROPE DRUG-DEVICE COMBINATION MARKET: Europe vs REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE DRUG-DEVICE COMBINATION MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE DRUG-DEVICE COMBINATION MARKET: Multivariate Modelling

FIGURE 7 EUROPE DRUG-DEVICE COMBINATION MARKET: PRODUCT type LIFELINE CURVE

FIGURE 8 EUROPE DRUG-DEVICE COMBINATION MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 9 EUROPE DRUG-DEVICE COMBINATION MARKET: DBMR MARKET POSITION GRID

FIGURE 10 EUROPE DRUG-DEVICE COMBINATION MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 11 EUROPE DRUG-DEVICE COMBINATION MARKET: vendor share analysis

FIGURE 12 EUROPE DRUG-DEVICE COMBINATION MARKET: SEGMENTATION

FIGURE 13 THE increasing prevalence of chronic diseases and rising geriatric population are expected to drive THE EUROPE DRUG-DEVICE COMBINATION MARKET IN THE FORECAST PERIOD of 2021 to 2028

FIGURE 14 THE Auto-Injector segment is expected to account for the largest share of the EUROPE DRUG-DEVICE COMBINATION MARKET IN THE Year 2021 & 2028

FIGURE 15 Porter's 5 forces

FIGURE 16 Pestel's Model

FIGURE 17 DRIVERS, RESTRAINTS, Opportunities, and Challenges: EUROPE DRUG-DEVICE COMBINATION MARKET

FIGURE 18 PREVALENCE OF ASTHMA IN THE FOLLOWING COUNTRIES.

FIGURE 19 INCIDENCE OF CANCER, WHICH INCREASES WITH AGE

FIGURE 20 AGEING POPULATION In the world (in millions)

FIGURE 21 North AMERICA AGEING POPULATION (In million)

FIGURE 22 Europe AGEING POPULATION (In million)

FIGURE 23 Asia-pacific AGEING POPULATION (In million)

FIGURE 24 Medical Device Spending vs. National Health Expenditures, 2016

FIGURE 25 EUROPE DRUG-DEVICE COMBINATION MARKET: By PRODUCT, 2020

FIGURE 26 EUROPE DRUG-DEVICE COMBINATION MARKET: By PRODUCT, 2019-2028 (USD million)

FIGURE 27 EUROPE DRUG-DEVICE COMBINATION MARKET: By PRODUCT, CAGR (2021-2028)

FIGURE 28 EUROPE DRUG-DEVICE COMBINATION MARKET: By PRODUCT, LIFELINE CURVE

FIGURE 29 EUROPE DRUG-DEVICE COMBINATION MARKET: By APPLICATION, 2020

FIGURE 30 EUROPE DRUG-DEVICE COMBINATION MARKET: By APPLICATION, 2019-2028 (USD million)

FIGURE 31 EUROPE DRUG-DEVICE COMBINATION MARKET: By APPLICATION, CAGR (2021-2028)

FIGURE 32 EUROPE DRUG-DEVICE COMBINATION MARKET: By APPLICATION, LIFELINE CURVE

FIGURE 33 Europe drug-device combination MARKET: BY END USER, 2020

FIGURE 34 Europe drug-device combination MARKET: BY product, 2021-2028 (USD MILLION)

FIGURE 35 Europe drug-device combination MARKET: BY product, CAGR (2021-2028)

FIGURE 36 Europe drug-device combination MARKET: BY product, LIFELINE CURVE

FIGURE 37 Europe drug-device combination MARKET: BY distribution channel, 2020

FIGURE 38 Europe drug-device combination MARKET: BY distribution channel, 2021-2028 (USD MILLION)

FIGURE 39 Europe drug-device combination MARKET: BY distribution channel, CAGR (2021-2028)

FIGURE 40 Europe drug-device combination MARKET: BY distribution channel, LIFELINE CURVE

FIGURE 41 EUROPE DRUG-DEVICE COMBINATION MARKET: SNAPSHOT (2020)

FIGURE 42 EUROPE DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2020)

FIGURE 43 EUROPE DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2021 & 2028)

FIGURE 44 EUROPE DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2020 & 2028)

FIGURE 45 EUROPE DRUG-DEVICE COMBINATION MARKET: BY product (2021-2028)

FIGURE 46 EUROPE DRUG-DEVICE COMBINATION MARKET: COMPANY SHARE 2020 (%)

Browse Related Pages

Banner